Cargando…

Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study

Detalles Bibliográficos
Autores principales: Park, Sohee, Kim, Ju Hwan, Kim, Songhee, Kang, Jisu, Moon, Seoyoung, Kim, Seok Jin, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435565/
https://www.ncbi.nlm.nih.gov/pubmed/37591839
http://dx.doi.org/10.1038/s41408-023-00889-5
_version_ 1785092128419872768
author Park, Sohee
Kim, Ju Hwan
Kim, Songhee
Kang, Jisu
Moon, Seoyoung
Kim, Seok Jin
Shin, Ju-Young
author_facet Park, Sohee
Kim, Ju Hwan
Kim, Songhee
Kang, Jisu
Moon, Seoyoung
Kim, Seok Jin
Shin, Ju-Young
author_sort Park, Sohee
collection PubMed
description
format Online
Article
Text
id pubmed-10435565
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104355652023-08-19 Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study Park, Sohee Kim, Ju Hwan Kim, Songhee Kang, Jisu Moon, Seoyoung Kim, Seok Jin Shin, Ju-Young Blood Cancer J Correspondence Nature Publishing Group UK 2023-08-18 /pmc/articles/PMC10435565/ /pubmed/37591839 http://dx.doi.org/10.1038/s41408-023-00889-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Park, Sohee
Kim, Ju Hwan
Kim, Songhee
Kang, Jisu
Moon, Seoyoung
Kim, Seok Jin
Shin, Ju-Young
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title_full Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title_fullStr Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title_full_unstemmed Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title_short Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
title_sort comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large b-cell lymphomas: a retrospective external comparator study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435565/
https://www.ncbi.nlm.nih.gov/pubmed/37591839
http://dx.doi.org/10.1038/s41408-023-00889-5
work_keys_str_mv AT parksohee comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT kimjuhwan comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT kimsonghee comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT kangjisu comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT moonseoyoung comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT kimseokjin comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy
AT shinjuyoung comparisonoftisagenlecleucelwithconventionaltreatmentsforrelapsedrefractorydiffuselargebcelllymphomasaretrospectiveexternalcomparatorstudy